Oppenheimer Maintains an 'Outperform' on Endologix (ELGX); Q4 has Several Catalysts
Tweet Send to a Friend
Oppenheimer maintains an 'Outperform' on Endologix (NASDAQ: ELGX) price target of $16.00.
Analyst, Steven Lichtman, said, "ELGX shares are ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Steven Lichtman, said, "ELGX shares are ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
